NASDAQ: EUDAEuda Health Holdings Ltd Stock
$2.33+0.03 (+1.3%)
Updated May 17, 2024
EUDA Price
$2.33
Fair Value Price
-$0.62
Market Cap
$57.38M
52 Week Low
$0.43
52 Week High
$2.50
P/E
-5.3x
P/B
-7.65x
P/S
8.84x
PEG
N/A
Dividend Yield
N/A
Revenue
$3.71M
Earnings
-$10.04M
Gross Margin
22.7%
Operating Margin
-270.24%
Profit Margin
-270.9%
Debt to Equity
-1.17
Operating Cash Flow
-$3M
Beta
-0.15
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A
EUDA Overview
8i Acquisition 2 Corporation is a "blank check" company formed to effect mergers, stock purchases, or similar combinations with one or more businesses. It targets companies in Asia. 8i Acquisition 2 was incorporated in 2021 and is headquartered in Singapore.
Zen Score
–
Industry Average (25)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how EUDA scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
EUDA ($2.33) is overvalued by 478.73% relative to our estimate of its Fair Value price of -$0.62 based on Discounted Cash Flow (DCF) modelling
Below Fair Value Valuation
EUDA ($2.33) is not significantly undervalued (478.73%) relative to our estimate of its Fair Value price of -$0.62 based on Discounted Cash Flow (DCF) modelling, when including a healthy margin of safety
Significantly Below Fair Value Valuation
EUDA is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more EUDA due diligence checks available for Premium users.
Be the first to know about important EUDA news, forecast changes, insider trades & much more!
EUDA News
Valuation
EUDA fair value
Fair Value of EUDA stock based on Discounted Cash Flow (DCF)
Price
$2.33
Fair Value
-$0.62
Undervalued by
478.73%
EUDA ($2.33) is overvalued by... subscribe to Premium to read more.
Below Fair Value Valuation
EUDA ($2.33) is not significantly... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
EUDA is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
EUDA price to earnings (PE)
For valuing profitable companies with steady earnings
Company
-5.3x
Industry
9.15x
Market
30.97x
EUDA price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
-7.65x
Industry
3.33x
EUDA's financial health
Profit margin
Revenue
$0.0
Net Income
$0.0
Profit Margin
0%
EUDA's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
EUDA's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$1.3M
Liabilities
$8.8M
Debt to equity
-1.17
EUDA's short-term liabilities ($8.72M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
EUDA's short-term assets ($723.44k) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
EUDA's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
EUDA's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
N/A
Investing
N/A
Financing
N/A
EUDA's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials
EUDA vs Health Information Service Stocks
Euda Health Holdings Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.